Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.

By J. Pardeike, A. Hommoss, R. Müller. International journal of pharmaceutics, 2009

1,408 citations recorded by the source corpus.

Subfields: Dermatology, Food Science, Pharmaceutical Science

View Paper: https://www.semanticscholar.org/paper/b5095eaf327b5763eddb94852bdd7abc1376a476

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Dermatology

1. Surajit Das
2. Anumita Chaudhury

In Food Science

1. A. Rodríguez-Gascón
2. P. Zakeri-Milani
3. Neda Naseri
4. F. Shahidi
5. Surajit Das
6. A. Beloqui
7. Anumita Chaudhury
8. V. Préat

In Pharmaceutical Science

1. Christopher J. H. Porter
2. P. Zakeri-Milani
3. Neda Naseri
4. H. Valizadeh
5. W. Charman
6. Natalie L. Trevaskis
7. S. Charman
8. H. Williams

Citations in the corpus

• Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages (2018, neutral): “Today, most of the commercially available products from lipid nanoparticles are cosmetic products such as Cutanova Cream Nano Repair Q10, Intensive Serum Nano Repair Q10, Cutanova Cream Nano Vital Q10, SURMER Crème Legère Nano-Protection, SURMER Crème Riche Nano-Restructurante, SURMER Elixir du Beau”
• Nanostructured lipid carriers: Promising drug delivery systems for future clinics. (2016, methodology): “Rimpler GmbH).(6,37) LPs protect incorporated active molecules against chemical degradation and allow modulating drug release, thus leading to the use of labile active ingredients, which cannot be utilized in traditional formulations.”
• Hesperetin-Loaded Solid Lipid Nanoparticles and Nanostructure Lipid Carriers for Food Fortification: Preparation, Characterization, and Modeling (2013, background): “Solid lipid nanoparticles (SLN) and nanostructure lipid carriers (NLC) are the new generations of nanovehicles and attracting increasing attention as the novel colloidal sensitive carriers in scientific and industrial applications (Pardeike et al. 2009).”
• Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery (2011, methodology): “The figure was reproduced from ( 119 ) with permission Recent Advances in Lipid Nanoparticle Formulations 63”
• Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application. (2015, background): “of SLNs and NLCs SLNs were presented since 1990 as a substitute carrier system to liposomes, emulsions and polymeric nanoparticles.(17) They have an average size of 40 to 1000 nm and a spherical morphology that can be studied with TEM (Transmission electron microscopy) and SEM (scanning electron mic”
• Strategies to Address Low Drug Solubility in Discovery and Development (2013, background): “Descriptions of SLN formulations for dermal application or sustained and targeted drug release are beyond the scope of the present review, but they have been extensively reviewed (zur Mühlen et al., 1998; Boyd, 2008; Pardeike et al., 2009).”